These findings demonstrate that CUR may have the potential to reverse the development of depression, and they indicate that the antidepressant mechanisms of CUR are associated with the activation of the PGC-1α/FNDC5/BDNF pathway. Here, PPARGC1A is linked to major depressive disorder.